Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Gastroenterology"
DOI: 10.1007/s00535-018-1518-3
Abstract: BackgroundFew studies have clearly identified the prognostic factors in patients with advanced biliary tract cancer (BTC) receiving gemcitabine plus cisplatin (GC) which is acknowledged as standard chemotherapy regimen.ObjectivesThe aim of this study was to identify… read more here.
Keywords: biliary tract; chemotherapy; tract cancer; advanced biliary ... See more keywords
Effect of ribonucleotide reductase M1 expression on overall survival in patients with pancreatic cancer receiving gemcitabine chemotherapy: A literature‐based meta‐analysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.12655
Abstract: The prognostic value of ribonucleotide reductase M1 (RRM1) in patients with pancreatic cancer receiving gemcitabine chemotherapy has been evaluated in several studies. However, the conclusions remain controversial. read more here.
Keywords: gemcitabine chemotherapy; cancer receiving; pancreatic cancer; patients pancreatic ... See more keywords